BETTERLIFE PHARMA INC. Diluted Earnings Loss Per Share
BETTERLIFE PHARMA INC. (BETRF) reported Diluted Earnings Loss Per Share of -0.03 CAD/shares for the 12-month period ending 2025-01-31, per its 20-F filed 2025-06-02.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2025-06-02
| Period end | Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2025-01-31 | -0.03 CAD/shares 20-F · filed 2025-06-02 |
| 2024-01-31 | -0.03 CAD/shares 20-F · filed 2025-06-02 |
| 2023-01-31 | -0.10 CAD/shares 20-F · filed 2025-06-02 |
| 2022-01-31 | -0.16 CAD/shares 20-F · filed 2024-05-30 |
| 2021-01-31 | -1.34 CAD/shares 20-F/A · filed 2023-06-06 |
| 2020-01-31 | -1.30 CAD/shares 20-F · filed 2022-06-06 |
| 2019-01-31 | -1.03 CAD/shares 20-F/A · filed 2021-06-23 |